Diagnostic Value of Angiography-Derived IMR for Coronary Microcirculation and Its Prognostic Implication After PCI

Neng Dai, Wenliang Che, Lu Liu, Wen Zhang, Guoqing Yin, Bin Xu, Yawei Xu, Shaofeng Duan, Haojun Yu, Chenguang Li, Kang Yao, Dong Huang, Junbo Ge, Neng Dai, Wenliang Che, Lu Liu, Wen Zhang, Guoqing Yin, Bin Xu, Yawei Xu, Shaofeng Duan, Haojun Yu, Chenguang Li, Kang Yao, Dong Huang, Junbo Ge

Abstract

Background: Angiography-derived index of microcirculatory resistance (angio-IMR) is an emerging pressure-wire-free index to assess coronary microvascular function, but its diagnostic and prognostic value remains to be elucidated. Methods and Results: The study population consisted of three independent cohorts. The internal diagnostic cohort enrolled 53 patients with available hyperemic microcirculatory resistance (HMR) calculated from myocardial blood flow and pressure. The external diagnostic cohort included 35 ischemia and no obstructive coronary artery disease (INOCA) patients and 45 controls. The prognostic cohort included 138 coronary artery disease (CAD) patients who received PCI. Angio-IMR was calculated after the estimation of angiography-derived fractional flow reserve (angio-FFR) using the equation of angio-IMR = estimated hyperemic Pa × angio-FFR × [vessel length/(K × Vdiastole)]. The primary outcome was a composite of cardiac death or readmission due to heart failure at 28 months after index procedure. Angio-IMR demonstrated a moderate correlation with HMR (R = 0.74, p < 0.001) and its diagnostic accuracy, sensitivity, specificity, and area under the curve to diagnose INOCA were 79.8, 83.1, 78.0, and 0.84, respectively, with a best cut-off of 25.1. Among prognostic cohort, patients with angio-IMR ≥25.1 showed a significantly higher risk of cardiac death or readmission due to heart failure than those with an angio-IMR <25.1 (18.6 vs. 5.4%, adjusted HR 9.66, 95% CI 2.04-45.65, p = 0.004). Angio-IMR ≥25.1 was an independent predictor for cardiac death or readmission due to heart failure (HR 11.15, 95% CI 1.76-70.42, p = 0.010). Conclusions: Angio-IMR showed a moderate correlation with HMR and high accuracy to predict microcirculatory dysfunction. Angio-IMR measured after PCI predicts the risk of cardiac death or readmission due to heart failure in patients with CAD. Clinical Trial Registration: Diagnostic and Prognostic Value of Angiography-derived IMR (CHART-MiCro), NCT04825028.

Keywords: INOCA; coronary microcirculation; functional angiography; index of microcirculatory resistance; prognosis.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Dai, Che, Liu, Zhang, Yin, Xu, Xu, Duan, Yu, Li, Yao, Huang and Ge.

Figures

Figure 1
Figure 1
Study flow. The study population was composed of internal and external diagnostic cohorts and prognostic cohort. Internal diagnostic cohort was used to evaluate the correlation between angio-IMR and HMR; external diagnostic cohort was used to evaluate the diagnostic performance of angio-IMR to diagnose INOCA. Prognostic cohort was used to evaluate the prognostic implication of angio-IMR in CAD patients after PCI. Angio-IMR, angiography-derived index of microcirculatory resistance; CAD, coronary artery disease; HMR, hyperemic microcirculatory resistance; INOCA, ischemia and no obstructive coronary artery disease; PCI, percutaneous coronary intervention.
Figure 2
Figure 2
Case examples of angiography-derived physiologic indices. A representative case of CZT-SPECT MBF, pressure wire FFR, and angio-IMR measurements, as well as how HMR are calculated from MBF and coronary pressure, are shown. (A) Coronary angiography; (B) CZT-SPECT MBF; (C) Pressure wire– measured FFR; (D) Calculation of HMR using coronary pressure and MBF data; (E) Angiography-derived FFR and IMR. CZT-SPECT, cadmium–zinc–telluride single-photon emission computed tomography; FFR, fractional flow reserve; HMR, hyperemic microcirculatory resistance; IMR, index of microcirculatory resistance; MBF, myocardial blood flow.
Figure 3
Figure 3
Correlation of angiography-derived FFR with invasive FFR and angiography-derived IMR and HMR in diagnostic cohort. The correlation and agreement between (A) angio-FFR and pressure wire–derived FFR, and (B) angio-IMR and coronary pressure and myocardial blood flow calculated HMR. Abbreviations are listed in Figures 1, 2.
Figure 4
Figure 4
Diagnostic accuracy of angiography-derived IMR to diagnose INOCA in external validation cohort. (A) Mean angio-IMR values in vessels with abnormal (INOCA) and normal (internal controls) corresponding CZT-SPECT perfusion territory among INOCA patients and in vessels among patients with normal CZT-SPECT perfusion imaging and angiography (normal controls); (B) ROC of angio-IMR to diagnose INOCA and (C) diagnostic performances of angio-IMR to diagnose INOCA are shown. AUC, area under curve; BCV, best cut-off value; LR, likelihood ratio; NPV, negative predictive value; PPV, positive predictive value; others are with Figure 1.
Figure 5
Figure 5
Comparison of primary and secondary outcomes at 28 months after index procedure according to angiography-derived IMR. Cumulative incidences of cardiac death or readmission due to (A) heart failure; (B) cardiac death or readmission due to heart failure and angina; (C) readmission due to heart failure; and (D) readmission due to angina at 28 months are presented according to the best cut-off value of angio-IMR. CI, confidence intervals; HRadj, multivariable adjusted hazard ratios; others are with Figure 1.
Figure 6
Figure 6
Diagnostic Value of Angiography-derived Index of Microcirculatory Resistance for Coronary Microcirculation and Its Prognostic Implication after PCI in CAD Patients. The current study evaluated diagnostic and prognostic implications of angiography-derived IMR. In diagnostic cohorts, angio-IMR showed a close correlation with HMR calculated as the ratio of hyperemic coronary pressure to myocardial blood flow, and a high diagnostic accuracy to predict patients with microcirculatory dysfunction. In prognostic cohort, patients with post-PCI impaired microcirculatory function assessed by angio-IMR ≥ 25.1U showed significantly higher risk of cardiac death or readmission due to heart failure than those with preserved microcirculatory function assessed by angio-IMR

References

    1. Alexander KP, Weisz G, Prather K, James S, Mark DB, Anstrom KJ, et al. . Effects of ranolazine on angina and quality of life after percutaneous coronary intervention with incomplete revascularization: results from the ranolazine for incomplete vessel revascularization (RIVER-PCI) trial. Circulation. (2016) 133:39–47. 10.1161/CIRCULATIONAHA.115.019768
    1. Fearon WF, Balsam LB, Farouque HM, Caffarelli AD, Robbins RC, Fitzgerald PJ, et al. . Novel index for invasively assessing the coronary microcirculation. Circulation. (2003) 107:3129–32. 10.1161/01.CIR.0000080700.98607.D1
    1. Chamuleau SA, Siebes M, Meuwissen M, Koch KT, Spaan JA, Piek JJ. Association between coronary lesion severity and distal microvascular resistance in patients with coronary artery disease. Am J Physiol Heart Circ Physiol. (2003) 285:H2194–200. 10.1152/ajpheart.01021.2002
    1. Collet C, Onuma Y, Sonck J, Asano T, Vandeloo B, Kornowski R, et al. . Diagnostic performance of angiography-derived fractional flow reserve: a systematic review and Bayesian meta-analysis. Eur Heart J. (2018) 39:3314–21. 10.1093/eurheartj/ehy445
    1. Li J, Gong Y, Wang W, Yang Q, Liu B, Lu Y, et al. . Accuracy of computational pressure-fluid dynamics applied to coronary angiography to derive fractional flow reserve: FLASH FFR. Cardiovasc Res. (2020) 116:1349–56. 10.1093/cvr/cvz289
    1. Liu L, Abdu FA, Yin G, Xu B, Mohammed AQ, Xu S, et al. . Prognostic value of myocardial perfusion imaging with D-SPECT camera in patients with ischemia and no obstructive coronary artery disease (INOCA). J Nucl Cardiol. (2020). [Epub ahead of print]. 10.1007/s12350-020-02252-8
    1. Li C, Xu R, Yao K, Zhang J, Chen S, Pang L, et al. . Functional significance of intermediate coronary stenosis in patients with single-vessel coronary artery disease: a comparison of dynamic SPECT coronary flow reserve with intracoronary pressure-derived fractional flow reserve (FFR). J Nucl Cardiol. (2020). [Epub ahead of print]. 10.1007/s12350-020-02293-z
    1. Leppo JA, Meerdink DJ. Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium. Circ Res. (1989) 65:632–9. 10.1161/01.RES.65.3.632
    1. Henzlova MJ, Duvall WL, Einstein AJ, Travin MI, Verberne HJ. Erratum to: ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers. J Nucl Cardiol. (2016) 23:640–42. 10.1007/s12350-016-0463-x
    1. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. . Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. (1998) 97:535–43. 10.1161/01.CIR.97.6.535
    1. Lee JM, Hwang D, Park J, Zhang J, Tong Y, Kim CH, et al. . Exploring coronary circulatory response to stenosis and its association with invasive physiologic indexes using absolute myocardial blood flow and coronary pressure. Circulation. (2017) 136:1798–808. 10.1161/CIRCULATIONAHA.117.029911
    1. Ai H, Feng Y, Gong Y, Zheng B, Jin Q, Zhang HP, et al. . Coronary angiography-derived index of microvascular resistance. Front Physiol. (2020) 11:605356. 10.3389/fphys.2020.605356
    1. Johnson NP, Kirkeeide RL, Asrress KN, Fearon WF, Lockie T, Marques KM, et al. . Does the instantaneous wave-free ratio approximate the fractional flow reserve? J Am Coll Cardiol. (2013) 61:1428–35. 10.1016/j.jacc.2012.09.064
    1. Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, et al. . Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document. Circulation. (2018) 137:2635–50. 10.1161/CIRCULATIONAHA.117.029289
    1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. . Third universal definition of myocardial infarction. Circulation. (2012) 126:2020–35. 10.1161/CIR.0b013e31826e1058
    1. Venkitachalam L, Kip KE, Mulukutla SR, Selzer F, Laskey W, Slater J, et al. . Temporal trends in patient-reported angina at 1 year after percutaneous coronary revascularization in the stent era: a report from the National Heart, Lung, and Blood Institute-sponsored 1997-2006 dynamic registry. Circ Cardiovasc Qual Outcomes. (2009) 2:607–15. 10.1161/CIRCOUTCOMES.109.869131
    1. Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, et al. . Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (fractional flow reserve versus angiography for multivessel evaluation) study. J Am Coll Cardiol. (2010) 56:177–84. 10.1016/j.jacc.2010.04.012
    1. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. . Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. (2007) 356:1503–16. 10.1056/NEJMoa070829
    1. Huqi A, Morrone D, Guarini G, Capozza P, Orsini E, Marzilli M. Stress testing after complete and successful coronary revascularization. Can J Cardiol. (2016) 32:986 e23–9. 10.1016/j.cjca.2015.12.025
    1. Jespersen L, Hvelplund A, Abildstrom SZ, Pedersen F, Galatius S, Madsen JK, et al. . Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. (2012) 33:734–44. 10.1093/eurheartj/ehr331
    1. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. . 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. (2020) 41:407–77. 10.1093/eurheartj/ehz425
    1. Lee BK, Lim HS, Fearon WF, Yong AS, Yamada R, Tanaka S, et al. . Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation. (2015) 131:1054–60. 10.1161/CIRCULATIONAHA.114.012636
    1. Feher A, Sinusas AJ. Quantitative assessment of coronary microvascular function: dynamic single-photon emission computed tomography, positron emission tomography, ultrasound, computed tomography, and magnetic resonance imaging. Circ Cardiovasc Imaging. (2017) 10:e006427. 10.1161/CIRCIMAGING.117.006427
    1. Dhawan SS, Corban MT, Nanjundappa RA, Eshtehardi P, McDaniel MC, Kwarteng CA, et al. . Coronary microvascular dysfunction is associated with higher frequency of thin-cap fibroatheroma. Atherosclerosis. (2012) 223:384–8. 10.1016/j.atherosclerosis.2012.05.034
    1. Taqueti VR, Everett BM, Murthy VL, Gaber M, Foster CR, Hainer J, et al. . Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation. (2015) 131:528–35. 10.1161/CIRCULATIONAHA.114.009716
    1. Carrick D, Haig C, Ahmed N, Carberry J, Yue May VT, McEntegart M, et al. . Comparative prognostic utility of indexes of microvascular function alone or in combination in patients with an acute st-segment-elevation myocardial infarction. Circulation. (2016) 134:1833–1847. 10.1161/CIRCULATIONAHA.116.022603
    1. Fearon WF, Low AF, Yong AS, McGeoch R, Berry C, Shah MG, et al. . Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention. Circulation. (2013) 127:2436–41. 10.1161/CIRCULATIONAHA.112.000298
    1. Nishi T, Murai T, Ciccarelli G, Shah SV, Kobayashi Y, Derimay F, et al. . Prognostic value of coronary microvascular function measured immediately after percutaneous coronary intervention in stable coronary artery disease: an international multicenter study. Circ Cardiovasc Interv. (2019) 12:e007889. 10.1161/CIRCINTERVENTIONS.119.007889

Source: PubMed

3
Suscribir